We observed that kinase activity profiles varied between tumor intrinsic subtypes, with a highly hyperactive Phos2 (hyperactivity of PI3K/AKT and mTOR signaling members, PTK2, SRC, EPHA2 kinases) and a less active Phos1 subtype. The gene discussed is EPHA2; the disease is neoplasm.